These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17141966)

  • 41. Effect of Bauhinia forficata aqueous extract on the maternal-fetal outcome and oxidative stress biomarkers of streptozotocin-induced diabetic rats.
    Volpato GT; Damasceno DC; Rudge MV; Padovani CR; Calderon IM
    J Ethnopharmacol; 2008 Feb; 116(1):131-7. PubMed ID: 18155864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrauterine growth restriction: implications for placental metabolism and transport. A review.
    Cetin I; Alvino G
    Placenta; 2009 Mar; 30 Suppl A():S77-82. PubMed ID: 19144403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
    Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
    Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diabetes mellitus in pregnancy].
    Haram K; Thordarson H; Nedrebø BG; Reigstad H
    Tidsskr Nor Laegeforen; 1996 Nov; 116(29):3452-8. PubMed ID: 9019848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery.
    Dy J; Guan H; Sampath-Kumar R; Richardson BS; Yang K
    Placenta; 2008 Feb; 29(2):193-200. PubMed ID: 18061258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
    Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
    Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short-term intensive glycemic control improves vibratory sensation in type 2 diabetes.
    Fujita Y; Fukushima M; Suzuki H; Taniguchi A; Nakai Y; Kuroe A; Yasuda K; Hosokawa M; Yamada Y; Inagaki N; Seino Y
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e16-9. PubMed ID: 18262304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Male sex and pre-existing diabetes are independent risk factors for stillbirth.
    Engel PJ; Smith R; Brinsmead MW; Bowe SJ; Clifton VL
    Aust N Z J Obstet Gynaecol; 2008 Aug; 48(4):375-83. PubMed ID: 18837843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [How and why does the metabolic equilibrium of the mother affect the embryo?].
    Fontaine P
    Diabetes Metab; 2001 Sep; 27(4 Pt 2):S13-8. PubMed ID: 11787431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nicotine-induced prenatal overexposure to maternal glucocorticoid and intrauterine growth retardation in rat.
    Chen M; Wang T; Liao ZX; Pan XL; Feng YH; Wang H
    Exp Toxicol Pathol; 2007 Nov; 59(3-4):245-51. PubMed ID: 17881205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of intrauterine growth restriction with maternal growth hormone supplementation in sheep.
    de Boo HA; Eremia SC; Bloomfield FH; Oliver MH; Harding JE
    Am J Obstet Gynecol; 2008 Nov; 199(5):559.e1-9. PubMed ID: 18599015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes.
    Cowans NJ; Spencer K; Meiri H
    Prenat Diagn; 2008 Feb; 28(2):121-5. PubMed ID: 18186153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neonatal lupus and IUGR following alpha-interferon therapy during pregnancy.
    Fritz M; Vats K; Goyal RK
    J Perinatol; 2005 Aug; 25(8):552-4. PubMed ID: 16047033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vascular complications in diabetic pregnancy.
    Kaaja R
    Thromb Res; 2009; 123 Suppl 2():S1-3. PubMed ID: 19217462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of the placenta in intrauterine growth restriction (IUGR).
    Cetin I; Antonazzo P
    Z Geburtshilfe Neonatol; 2009 Jun; 213(3):84-8. PubMed ID: 19536707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrauterine growth restriction in a rodent model and developmental programming of the metabolic syndrome: a critical appraisal of the experimental evidence.
    Neitzke U; Harder T; Schellong K; Melchior K; Ziska T; Rodekamp E; Dudenhausen JW; Plagemann A
    Placenta; 2008 Mar; 29(3):246-54. PubMed ID: 18207235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sheep models of intrauterine growth restriction: fetal adaptations and consequences.
    Morrison JL
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):730-43. PubMed ID: 18498533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced maternal serum concentrations of angiopoietin-2 in the first trimester precede intrauterine growth restriction associated with placental insufficiency.
    Wang Y; Tasevski V; Wallace EM; Gallery ED; Morris JM
    BJOG; 2007 Nov; 114(11):1427-31. PubMed ID: 17949380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surface area of chorionic villi of placentas: an index of intrauterine growth restriction of fetuses.
    Biswas S; Ghosh SK; Chhabra S
    J Obstet Gynaecol Res; 2008 Aug; 34(4):487-93. PubMed ID: 18937701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TNF-alpha gene polymorphism and fetal Doppler velocimetry in intrauterine growth restriction.
    Seremak-Mrozikiewicz A; Dubiel M; Drews K; Gudmundsson S; Mrozikiewicz PM
    Neuro Endocrinol Lett; 2008 Aug; 29(4):493-9. PubMed ID: 18766139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.